A carregar...
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
The human gut microbiota metabolizes the Parkinson’s disease medication Levodopa (L-dopa), potentially reducing drug availability and causing side effects. However, the organisms, genes, and enzymes responsible for this activity in patients and their susceptibility to inhibition by host-targeted dru...
Na minha lista:
| Publicado no: | Science |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association for the Advancement of Science
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7745125/ https://ncbi.nlm.nih.gov/pubmed/31196984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aau6323 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|